Active, Not Recruiting
Acalabrutinib in Combination With ACP-319, for Treatment of Chronic Lymphocytic Leukemia
NCT02157324
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- Research Site Columbus, Ohio, United States
- Research Site Hermitage, Tennessee, United States
- Research Site Fort Worth, Texas, United States